Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

TAK-700 in Castration Resistant Prostate Cancer

by on Tuesday, August 7th, 2012 | No Comments

Condition:   Prostate Cancer
Interventions:   Drug: Orteronel;   Drug: Bicalutamide
Sponsors:   European Organization for Research and Treatment of Cancer – EORTC;   European Organization for Research and Treatment of Cancer – EORTC
Not yet recruiting – verified August 2012

Read more: TAK-700 in Castration Resistant Prostate Cancer



Tags: , , , , , , ,
Posted in Cancer Clinical Trials

Comments are closed.